IPO
-
-
-
-
-
-
-
TransMedics Announces Temporary PostponementĀ of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
-
-
-
-
-
-
-
TransMedics Reports Second Quarter 2019 Financial Results
-
-
-
-
-
-
-
TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations o
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

